ScienceMed®

Escolha do padrão de crescimento e interpretação de grandes resultados da idade gestacional: evidência do ensaio CDC4G

Endocrinologia
Imagem de arquivo, ilustrativa — não é do estudo. Placenta a termo com calcificação, ao microscópio óptico. Mikael Häggström · CC0 · Wikimedia Commons

Ensaio clínico randomizadoNível 2 · Nova evidênciaPaediatric and perinatal epidemiology29 jul 20260 citações

Salvar

Resumo original em inglês

O que aconteceu

The lack of a standardised definition of large for gestational age (LGA) complicates clinical assessments and the interpretation of research.

The objective of this study is to assess how different definitions of LGA affect the interpretation of outcomes in a stepped wedge cluster randomised controlled trial (SW-CRT).

Secondary analysis of the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G, ISRCTN41918550) study population (n = 47,080 pregnancies), including eight delivery units in Sweden during 2018. The outcome measures were the prevalence of LGA and severe LGA before and after switching from the previous Swedish diagnostic criteria for gestational diabetes (SWE-GDM) to the World Health Organisation (WHO-2013) criteria. LGA and severe LGA were defined as birthweight > 90th and > 97th percentile, respectively, using the following reference growth charts: The new Swedish reference ranges for fetal weight (SWE-REF), the Gestation Related Optimal Weight (GROW) and the International Fetal and Newborn Growth Consortium for the 21st Century (Intergrowth-21st). Analyses were performed on a modified intention-to-treat (mITT) population and on the subgroup discordant for GDM diagnosis between new and former criteria, i.e., glucose levels between the WHO-2013 and SWE-GDM diagnostic thresholds.

O que encontraram

In the mITT population, the prevalence of LGA decreased from 19.4% to 13.1% after the switch to the WHO-2013 GDM criteria, as defined by SWE-REF (adjusted relative risk [RR], 0.92; 95% confidence interval [CI] 0.86, 0.98). There was no change in severe LGA using any of the reference charts. In the subgroup, LGA defined by SWE-REF (RR 0.68, 95% CI 0.50, 0.91) and GROW (RR 0.78, 95% CI 0.63, 0.95) was reduced, but not when defined by Intergrowth-21st (RR 0.88, 95% CI 0.74, 1.06). Severe LGA was reduced only when defined by Intergrowth-21st (RR 0.73, 95% CI 0.62, 0.85).

Por que isso importa

The choice of LGA definition affected the interpretation of the results in the CDC4G trial.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Choice of Growth Standard and Interpretation of Large for Gestational Age Outcomes: Evidence From the CDC4G Trial

Sara Grass, Maryam de Brun, Anders Magnuson, Martina Persson, Anna-Karin Wikström, David Simmons, Snehal Patil, Verena Sengpiel, Scott Montgomery, Kerstin Berntorp et al.

Descritores MeSH

  • Diabetes, Gestational
  • Birth Weight
  • Infant, Large for Gestational Age
  • Fetal Macrosomia
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Outcome
  • Reference Standards

Veja também

Estudos relacionados